The government announced it was ramping up its coronavirus vaccination programme last week - offering millions more jabs to adults in the UK as it gradually attempts to ease lockdown restrictions.
And there's been concern as a number of countries have temporarily suspended the use of the Oxford/AstraZeneca vaccine as reports of blood clots in people who have had the vaccine are investigated.
Earlier, Professor Andrew Pollard said that while it was right that regulators investigated reports of blood clots in people who have had the vaccine, data from millions of people was “very reassuring” that there was no link.
It comes after the Netherlands became the latest country to suspend use of the Oxford/AstraZeneca vaccine over concerns about possible side-effects.
The Dutch government said the precautionary move will last until at least March 29, following a similar decision made by the government in Ireland.
Denmark, Norway, Bulgaria, Iceland and Thailand have all temporarily suspended their use of the AstraZeneca jab.
Last week, the World Health Organisation (WHO), the European Medicines Agency (EMA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said there was no evidence of a link between the jab and an increased risk of blood clots.
But when are you likely to receive your vaccine - if you are a UK resident and over 18?
This vaccination calculator gives you an idea of when it is likely to be.
The phase one list is as follows, in order of priority:
1) Residents in a care home for older adults and their carers
2) All those 80 years of age and over and frontline health and social care workers
3) All those 75 years of age and over
4) All those 70 years of age and over and clinically extremely vulnerable individuals
5) All those 65 years of age and over
6) All individuals aged 16 to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality
7) All those 60 years of age and over
8) All those 55 years of age and over
9) All those 50 years of age and over
Phase two:
1)All those aged 40-49
2) All those aged 30-39
3) All those aged 18-29
